Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New device aims to tighten skin safely in all skin types

NCT ID NCT07224880

First seen Nov 05, 2025 · Last updated May 23, 2026 · Updated 29 times

Summary

This study is testing a device called Ellacor that uses tiny needles to remove small pieces of skin, aiming to reduce wrinkles and tighten loose skin on the face and belly. Researchers want to see if it works safely in people with different skin tones and in those taking GLP-1 medications (like Ozempic) for weight loss. Ten adults aged 30-65 will be followed for 90 days to check results and side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLP1 AGONIST are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Tri Valley Plastic Surgery

    RECRUITING

    Dublin, California, 94568, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.